EYES News and Press, Second Sight Medical Products Inc.

Gainers: GigaCloud Technology Inc Class A Ordinary Shares ( GCT ) +173% . Volcon ( VLCN ) +74% . Axsome Therapeutics ( AXSM ) +40% . Endo International plc ( ENDP ) +24% . Foot Locker ( FL ) +21% . Summit Therapeutics ( ...

Second Sight Medical Products, Inc. ( NASDAQ: EYES ), a maker of implantable visual prosthetics, dropped ~17% on Friday morning as its shares began trading on a split-adjusted basis following a 1-for-3 reverse stock split. In July, the company filed for an amendment to...

Gainers: Axsome Therapeutics AXSM +31% . Summit Therapeutics SMMT +25% . Assure Holdings ( IONM ) +13% . Longboard Pharmaceuticals ( LBPH ) +10% . TransCode Therapeutics ( RNAZ ) +8% . Losers: Accelerate Diagnostics AXDX -27...

Bed Bath & Beyond BBBY -43% after RC Ventures cuts entire stake ; taps restructuring lawyers for help with debt - Bloomberg Capstone Green Energy CGRN -41% after pricing ~$8M securities offering . Lizhi LIZI -18% on Q2 earnings release . Vin...

Applied DNA Sciences ( APDN ) +116% . Poseida Therapeutics ( PSTX ) +81% . Ping Identity Holding ( PING ) +60% Non-GAAP EPS of -$0.34 misses by $0.22, revenue of $72.03M misses by $1.27M. Alnylam Pharmaceuticals ( ALNY ) +47% as Phase 3 tr...

Second Sight ( NASDAQ: EYES ) said its shareholders approved its merger with Nano Precision Medical, changing the company's name to Vivani Medical Inc. and a reverse stock split among other proposals, at the annual meeting. In February, Second Sight said...

Second Sight to change its name to Vivani Medical, Inc. Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of u...

Second Sight Medical Products ( NASDAQ: EYES ) said it received the fourth year funding of $1.1M from the National Institutes of Health (NIH) for a trial of its artificial vision implant, Orion Visual Cortical Prosthesis System (Orion). The planned five-...

Grant proceeds support an ongoing early feasibility study of Orion Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an artificial for...

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight”), a recognized global leader in neuromodulation devices for blindness, today announced that an interview with Adam Mendelsohn, Ph.D., Co-Founder and CEO of Nano Precision Medical, Inc. (“NPM”)...